Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

SAN FRANCISCO, July 23 /PRNewswire/ --

InCode BioPharmaceutics, Inc., an emerging biopharmaceutical company, today announced preclinical test results demonstrating the utility of their lead drug candidate rC3-1 for the treatment of the rare chronic blood disorder paroxysmal nocturnal hemoglobinuria (PNH). The complete results will be presented at the XXII International Complement Workshop in Basel, Switzerland, September 28, 2008.

The only treatment currently available for PNH patients is an anti-C5 antibody Soliris(TM) (eculizumab) sold by Alexion Pharmaceuticals, Inc.

FRANKFURT, Germany and CHICAGO, Illinois, July 23 /PRNewswire/ --

RTS Realtime Systems Group, a leading trading solutions provider, announced that MexDer, the Mexican Derivatives Exchange, has selected RTS to provide the next generation front-end for its electronic trading platform. The agreement includes distribution of trading screens to MexDer local members including market makers, brokers and clearing firms.

RTS will provide its suite of trading solutions, which includes the high- performance trading platform, the RTD Realtime Trading Desktop, and the white-label version of RTS' Web-based front-end, eRTD. MexDer will work with RTS to roll out and install RTS' suite of front-end solutions to its Mexican exchange members.

LONDON, July 23 /PRNewswire/ -- Depending on where a European smoker lives, some will die 10 years sooner than their neighbours! This huge discrepancy is due to differing European levels of tobacco control, services and availability of clinically proven products. Smoking is a serious health inequalities issue which is now being tackled by the European Network of Quitlines thanks to funding from a Pfizer Foundations Global Health Partnership Programme.

PORTLAND, Oregon, July 23 /PRNewswire/ --

Site9, a Portland, Oregon based developer of collaborative web development software, today introduced ProtoShare. ProtoShare is the first online web development tool that enables website developers to easily build dynamic and navigable website prototypes that team members can then review and comment on in real-time. It is available online as a SaaS (Software-as-a-Service) tool with access available from any Internet connection.

PHILADELPHIA and LONDON, July 23 /PRNewswire/ --

- Recognized in Top 100 Most Technologically Significant Products

The Scientific business of Thomson Reuters today announced that it has received an R&D 100 Award for its intellectual property research and analysis platform, Thomson Innovation(SM) (www.thomsoninnovation.com). The R&D 100 Awards are presented annually by R&D Magazine and recognize the 100 most technologically significant products that have been introduced to the marketplace in the past year.

OXFORD, England, July 23 /PRNewswire/ -- B2M Solutions, specialists in managing the mobile enterprise, has signed Logistics International PLC as a certified reseller of its mprodigy(TM) mobile management system. Logistics International is also using mprodigy to manage the mobile equipment used by its own Field Engineering team across the UK and Europe.